Samarth Life Sciences Pvt Ltd
Leuprolide (3.75mg)
Eurolide 3.75mg Depot Injection is used to treat prostate cancer, endometriosis, uterine fibroids, and central precocious puberty.
Injection
Eurolide 3.75mg Depot Injection is used in the treatment of prostate cancer. It is also used to treat endometriosis (endometrium of the uterus grows excessively and causes symptoms like pain, heavy or irregular periods), uterine fibroids and central precocious puberty (very early puberty).
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Eurolide 3.75mg Depot Injection reduces the amount of sex hormones (testosterone in men and estrogen in women)..It works by decreasing the blood levels of testosterone in males..Eurolide 3.75mg Depot Injection also acts by shutting off hormones made by the ovaries (female reproductive organs) so the estrogen (one of the hormones that causes females to have periods) level is lowered.
Eurolide 3.75mg Depot Injection helps in the treatment of locally advanced or metastatic prostate cancer. It may also be used to treat endometriosis and uterine fibroids. It is given as an injection either under the skin or into a muscle. It may cause dizziness and visual disturbances. Don't drive or do anything that requires mental focus until you know how it affects you. Long term treatment may lead to bone loss and a higher risk of bone fractures especially if you are a heavy drinker, a smoker, or have a family history of osteoporosis.
No, Eurolide 3.75mg Depot Injection is not a chemotherapy medicine but rather a synthetic hormone analogue used for the treatment of hormone-dependent conditions in men and women.
While taking Eurolide 3.75mg Depot Injection, periods tend to stop as this medication alters reproductive hormones in females. In some cases, vaginal bleeding may occur; it is essential to consult your doctor for assessment and guidance.
Yes, Eurolide 3.75mg Depot Injection is a hormonal medication that affects reproductive hormones in females. This treatment is not recommended for use in women who are or may become pregnant as it can harm the fetus. Using this medicine during pregnancy may also lead to miscarriage.
Yes, there is a possibility of Eurolide 3.75mg Depot Injection affecting bone mineral density, making bones weaker. In women, especially those at increased risk of osteoporosis, bone density should be assessed before starting the treatment and appropriate measures taken if necessary.
Yes, Eurolide 3.75mg Depot Injection may cause an increase in blood sugar levels, potentially worsening glucose control in patients with diabetes. It can also increase the risk of developing diabetes. Regular monitoring of blood glucose and/or glycosylated hemoglobin (HbA1c) is recommended.